Jaguar Health, Inc.
JAGX
$0.32
-$0.05-13.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -243.32% | 138.37% | -142.70% | 8.70% | 0.54% |
| Total Depreciation and Amortization | 4.23% | -4.24% | -2.51% | 0.18% | 1.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 553.87% | -81.58% | 96.97% | -27.15% | 136.55% |
| Change in Net Operating Assets | 183.97% | -110.71% | 512.32% | 229.31% | -52.99% |
| Cash from Operations | -160.45% | 260.90% | -17.04% | 24.31% | 15.30% |
| Capital Expenditure | -- | -- | 124.07% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 124.07% | -- | -- |
| Total Debt Issued | -- | -- | -- | 100.00% | -100.09% |
| Total Debt Repaid | 95.37% | -3,685.29% | 14.57% | -37.24% | 39.08% |
| Issuance of Common Stock | -- | -- | -- | 48.08% | 59.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 285.56% | -1,225.00% | 114.04% | -280.00% | -76.47% |
| Cash from Financing | 128.15% | -167.57% | 56.41% | 135.74% | -46.54% |
| Foreign Exchange rate Adjustments | -88.24% | 270.00% | 94.90% | -443.86% | 58.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -255.65% | -48.15% | 226.14% | 137.90% | -50.65% |